2027 Printed Publications Early Bird Sale on Now through October 2, 2026!



User Information

Create New Account

Lost Password

Username:
Password:

Quick Links


LCDs and LCAs by
Contractor

PLA Codes

Laboratory Fee Schedule

2026
2025
QW Tests

Physician Fee Schedule

2026 non-QP

Physician Fee Schedule-QP

2026-QP

OPPS Fee Schedule

2026-July
2026-April

ASC Fee Schedule

2026-July
2026-April

APC Codes

2026-July
2026-April

DRG Codes

2026
2025

ASP Drug Pricing Files

2026-July
2026-April


CMS Transmittals



CodeMap® LCD-L39467

 

Printer Friendly Version

L39467
LCD for MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (L39467)

See related Articles:
A59521-Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59523-Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59524-Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

Contractor Information

Contractor Name: Noridian Healthcare Solutions, LLC - Full list of policies of this Medicare Contractor

Contractor Number: 01212

Contractor Type: MAC B

LCD Information

LCD ID Number: L39467 Status: A-Approved

LCD Title: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

Geographic Jurisdiction: American Samoa, Guam, Hawaii, Northern Mariana Islands Other Jurisdictions

Original Determination Effective Date: 10/15/2023

Original Determination Ending Date:

Revision Effective Date: 01/22/2026

Revision End Date:

CMS National Coverage Policy:

Title XVIII of the Social Security Act, §1862(a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary

42 CFR §410.32(a) Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions

CMS Internet-Only Manual, Pub. 100-02, Medicare Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests, §80.1.1 Certification Changes

 


Sorry, you need to login or register to view additional sections of this Medicare policy.

--
*


All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

09/16/2026 07:03:52 18.97.14.81

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.